Samsara BioCapital raises $260.6 mln for venture capital fund

Samsara BioCapital has raised $260.6 million toward a $300 million venture-capital fund, according to a filing with the SEC.

Fifty-one LPs contributed capital. The fund’s partners include former Sofinnova Ventures General Partner Srini Akkaraju and Michael Dybbs, a former partner at New Leaf Venture Partners. Akkaraju also worked at New Leaf.

The filing is available here.